Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase.
about
The Migraine-Stroke ConnectionThe Role of Adenosine Signaling in Headache: A Review.Cyclic AMP Accumulation in Migraine Induction.Reproducibility of migraine-like attacks induced by phosphodiesterase-3-inhibitor cilostazol.Laboratory tests of headache disorders - dawn of a new era?CGRP in human models of primary headaches.Migrainous infarction: a rare and often overlooked diagnosis.Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine.Cilostazol induces C-fos expression in the trigeminal nucleus caudalis and behavioural changes suggestive of headache with the migraine-like feature photophobia in female rats.Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks.Human models of migraine - short-term pain for long-term gain.The relationship between migraine and rosacea: Systematic review and meta-analysis.Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.Cilostazol as a chemically induced preclinical model of migraine.PACAP38 in human models of primary headaches.Toward a pragmatic migraine model for drug testing: 1. Cilostazol in healthy volunteersPre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers
P2860
Q26747260-6468FE82-7A8C-43F5-82FA-24BD0E6CBE1BQ37721517-A4DE6CE9-F464-4DFD-989A-526A6C177058Q38313663-187DFC70-6224-4E6E-A14F-AFAA00BAA65FQ38693250-6F71F553-0DC2-40B7-B3CB-D5F016719E8AQ38695434-46250392-B7F1-484B-828A-76CE53A7A29EQ38784420-D83F5144-D2FB-4635-9A55-DB61A92574FCQ39456116-8680DCDE-85CD-4CFE-A3DC-BA623D9D3C2FQ40844180-94B9CD97-2FC0-4BF9-895D-2EA2D02B136DQ40844188-176EFEAF-DDFB-4D38-A134-4DEE41963452Q41492299-441255F9-B602-4FD8-B399-CF0F960E1245Q47627456-574E41B6-073D-499A-AE20-DC3EFFA9DEE1Q47693056-01C8A090-0F6A-42E2-8F9F-9FDE79176B30Q47912532-E612AD10-8BF3-4A4E-97F0-4BFB5DDED413Q47944255-3E3C8DEA-6615-4458-8623-03073B3C82BCQ49283103-C2B08FE8-C76D-42FC-AA46-BEF7E4A3D1BCQ49793703-B8940498-96DD-41AC-8063-B512214579DFQ49907816-6A93D605-5561-45B5-A1CF-B8A220B0E267Q57023753-E363BD3F-FABE-4BE1-A4FF-335F96A6163DQ58771503-1F4B82E3-C238-4C9A-96E9-2C88D6AAAD23
P2860
Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@en
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@nl
type
label
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@en
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@nl
prefLabel
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@en
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@nl
P2860
P356
P1433
P1476
Phosphodiesterase 3 inhibitor ...... tacks via cyclic AMP increase.
@en
P2093
P2860
P304
P356
10.1093/BRAIN/AWU244
P407
P577
2014-08-26T00:00:00Z